Allergy Research Group® launches Essential-Biotic™ probiotic line

June 04, 2018

For Immediate Release

Allergy Research Group® will introduce a line of high quality evidence-based professional probiotics on July 1, 2018. Four products will initially be launched: Complete, Mature, Women’s and a tasty Children’s chewable tablet.

Each unique formula includes two clinically proven strains, Lactobacillus acidophilus DDS®-1 and Bifidobacterium lactis UABla-12™, to support digestion and immunity, as well as pediatric skin health.*

Essential-Biotic™ COMPLETE provides twelve researched human probiotic strains, with a high potency of 50 billion colony-forming units (CFUs) per delayed-release vegetarian capsule (DRcaps™).

Essential-BioticTM MATURE provides 25 billion CFUs per vegetarian DRcap™ of six human probiotic strains for adults 50+.

Essential-BioticTM WOMEN’S provides 25 billion CFUs per vegetarian DRcap™ of ten human probiotic strains to support female GI and genitourinary tract health.*

Essential-BioticTM CHILDREN’S provides 5 billion CFU’s per tasty, naturally-flavored, cherry chewable tablet, containing two probiotic strains shown in clinical trials to be safe and efficacious in children.*

All four probiotics are stable at room temperature, non-dairy and gluten-free.

To learn more about Essential-BioticTM, visit the ARG web site, or call our customer service team at 1-800-545-9960, extension 2.

CONTACT:
Allergy Research Group, LLC
Dan Mallar, National Sales Director
dan.mallar@allergyresearchgroup.com

DDS® and UABla-12™are trademarks of UAS Laboratories LLC and used under license.
With DRcaps™ Delayed Release capsules.  DRCAPS and DRCAPS and Design are trademarks used under license.

*This statement has not been evaluated by the U.S. Food and Drug administration. The product is not intended to diagnose, treat, cure, or prevent any disease.